Daily news email for July 29, 2012 | Click here for updated news
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report
India Preparing to Introduce Price Controls
Amarin Wins FDA Approval of Vascepa
Hyperion Therapeutics Goes Public
Supreme Court Ruling on Healthcare Reform Will Lower Costs
California's Stem Cell Agency Approves $150 Million Grants
|
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
New York Times- Pharmaceuticals
Imagine a World Without AIDS
Helping Patients in Need
The Long, Uphill Battle Against AIDS
Baldness Battle, Fought in the Follicle
For Big Drug Companies, a Headache Looms
|
OnBioVC
Stemgent, Inc.: Series C $6.3M
Genalyte, Inc.: Series A $11.8M
Relievant Medsystems, Inc.: Series D $30M
ImaginAb, Inc.: Series A $12.5M
BiO2 Medical, Inc.: Series B $13.7M
|
Outsourcing-Pharma
Wockhardt targets CMO space for diversification
Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles
Home visits = regulatory thumbs up ResearchNurses.co thinks so
Home visits are the key to patient retention, says ResearchNurses.co
Kemwell and Boehringer set to finish biologics plant in India
|
